Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The study is looking to compare the impact of lipid levels and HIV viral loads between three
different drug regimens: Continuing current regimen (ritonavir boosted regimen), Switching to
Atazanavir, or Switching to Atazanavir in combination to Ritonavir.